About 4 Trademarks found that are owned by Otter Pharmaceuticals Llc

Anti-arthritic compositions and preparations; chemical preparations for pharmaceutical or medical purposes, namely, for treatment of auto immune diseases and inflammatory diseases; medicinal preparations for treatment of inflammatory diseases and auto immune diseases; pharmaceutical preparations and substances for the treatment of pain and inflammation; pharmaceutical preparations for the prevention and treatment of auto immune diseases or disorders; pharmaceutical preparations for the treatment and prevention of auto immune diseases and inflammatory diseases; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases, namely, rheumatoid arthritis, juvenile idiopathic arthritis and psoriasis; pharmaceutical preparations for auto immune diseases and inflammatory diseases; pharmaceutical preparations for auto immune diseases and inflammatory diseases, namely, arthritis, juvenile idiopathic arthritis and psoriasis; pharmaceutical products for the treatment of joint disease

The mark consists of The mark consists of the word "OTREXUP" in Chino Medium font and in the color orange with the letter "O" capitalized. There is a sweeping element in the form of three wave like symbols, the first of which is just above the letter "U" and entirely in the color blue; the second and third wave like symbols begin to the right of the letter "P". The middle wave like symbol is in the color orange except for the top third which is in the color blue and arches over the letter "P". The final wave like symbol is entirely in the color orange and follows the curve of the middle symbol but does not stretch over any of the letters..

Pharmaceutical preparations for the treatment and management of central nervous system diseases and disorders and neurological disorders; Pharmaceutical preparations for the relief, treatment or amelioration of pain; Analgesic preparations; Anti-inflammatories; Pharmaceutical preparations, namely, drug delivery systems comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents

The color(s) orange and blue is/are claimed as a feature of the mark.